tiprankstipranks

Helen Louise Collins Insider Profile

4 Followers
Helen Louise Collins, EVP and Chief Medical Officer at Five Prime Therapeutics, holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX), holds ― shares in Kura Oncology (Ticker: KURA), holds 25.00K shares in Enliven Therapeutics (Ticker: ELVN).
tipranks
Helen Louise Collins

Helen Louise Collins
Five Prime Therapeutics (FPRX)
EVP and Chief Medical Officer

Not Ranked
Helen Louise Collins has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
0.00%
0.00%
A breakdown of Helen Louise Collins's holdings

Insider Roles

Enliven Therapeutics
(ELVN)
CMO
Kura Oncology
(KURA)
Director
IO Biotech
(IOBTQ)
Director
Roles that Helen Louise Collins holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Helen Louise Collins

Helen Louise Collins's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FPRX
Five Prime Therapeutics
Apr 19, 2021
Uninformative Buy
$0.00
Kura Oncology
Director
Enliven Therapeutics
Mar 27, 2026
CMO
Uninformative Buy
99.20K
$1.07M
IO Biotech
Director
List of latest transactions for each holding click on a transaction to see Helen Louise Collins's performance on stock

Helen Louise Collins insider profile FAQ

What is the percentage of profitable transactions made by Helen Louise Collins?
The percentage of profitable transactions made by Helen Louise Collins is ―.
    What is the average return per transaction made by Helen Louise Collins?
    The average return per transaction made by Helen Louise Collins is ―.
      What stocks does Helen Louise Collins hold?
      Helen Louise Collins holds: FPRX, KURA, ELVN, IOBTQ stocks.
        What was Helen Louise Collins’s latest transaction?
        Helen Louise Collins latest transaction was an Uninformative Buy of ―.
          What was Helen Louise Collins's most profitable transaction?
          Helen Louise Collins’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Helen Louise Collins's role in Five Prime Therapeutics?
            Helen Louise Collins's role in Five Prime Therapeutics is EVP and Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.